Half-year report · Q2
5957.TEDINET S100U6VF
Period2024-01-01 → 2024-06-30
Filed2024-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.4bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥44.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.4bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥1.5bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.6bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥834m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥975m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥54.7bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥53.3bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥53.4bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.8bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥16.9bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥37.9bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥36.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥35.7bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.6bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.3bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.4bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥807m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥539m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥483m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥27.56 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.95 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.57 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 61.3% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.7% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.2bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.2bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥328m |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥691m |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥539m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥6m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥6m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥64m |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥22.4bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥22.4bn |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥2.7bn |
| jpcrp040300-q2r_E02296-000Control Systemreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥70m |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥16.3bn |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥16.3bn |
| jpcrp040300-q2r_E02296-000Fastenerreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥800m |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥3.5bn |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥3.5bn |
| jpcrp040300-q2r_E02296-000Machineryreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥481m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥13m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥13m |
| jpcrp040300-q2r_E02296-000Medicalreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥53m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥22.4bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥22.4bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 560
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | 13048000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 22447807000 | JPY |
| Revenues from external customers | Prior1YTDDuration | 22447807000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 16260737000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 3453338000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 2720683000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | 13048000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 22447807000 | JPY |
| Net sales | Prior1YTDDuration | 22447807000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 800289000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 481263000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 69908000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | -52664000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1298796000 | JPY |
| Operating income | Prior1YTDDuration | 1298796000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 16038348000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 3138500000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 3212179000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | 5815000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 22394844000 | JPY |
| Revenues from external customers | CurrentYTDDuration | 22394844000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 16038348000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 3138500000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 3212179000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | 5815000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 22394844000 | JPY |
| Net sales | CurrentYTDDuration | 22394844000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02296-000FastenerReportableSegmentsMember | 690516000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MachineryReportableSegmentsMember | 539170000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02296-000ControlSystemReportableSegmentsMember | 328318000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02296-000MedicalReportableSegmentsMember | -63532000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1494473000 | JPY |
| Operating income | CurrentYTDDuration | 1494473000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-08-09 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第119期中（自 2024年１月１日 至 2024年６月30日） |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |